Table 1 Chronic diseases and assigned ATC-codes and medication classes
Chronic condition | ATC classification | Medication class |
|---|---|---|
Acid related disorders | A02 | Antacids |
Drugs for peptic ulcer and gastroesophageal reflux disease (GERD) | ||
Other drugs for acid related disorders | ||
Bone diseases (osteoporosis) | M05 | Drugs for treatment of bone diseases |
Cancer | L01 | Antineoplastic agents |
Cardiovascular diseases (incl. hypertension) | B01AA, B01AC, | Cardiac agents (excl. ACE inhibitors) |
C01, C04A, | Antihypertensives | |
C02, C07, | Peripheral vasodilators | |
C08, C09 | Beta blocking agents | |
Calcium channel blockers | ||
Agents acting on the renin-angiotensin system | ||
Vitamin K antagonists | ||
| Â | Platelet aggregation inhibitors (excl. herparin) | |
Dementia | N06D | Anti-dementia drugs |
Diabetes mellitus | A10A, A10B, | Insulins and analogues |
A10X | Blood glucose lowering drugs (excl. insulins) | |
Other drugs used in diabetes | ||
Epilepsy | N03 | Antiepileptics |
Glaucoma | S01E | Antiglaucoma preparations and miotics |
Gout, Hyperuricemia | M04 | Antigout preparations |
HIV | J05AE, J05AG, | Protease inhibitors |
J05AR | Non-nucleoside reverse transcriptase inhibitorsAntivirals for treatment of HIV infections, combinations | |
Hyperlipidemia | C10 | Lipid modifying agents |
Intestinal inflammatory diseases | A07EA, A07EC | Corticosteroids acting locallyAminosalicylic acid and similar agents |
Iron deficiency anemia | B03AA, B03AB, | Iron bivalent, oral prepartations |
Iron trivalent, oral preparations | ||
B03AC | Iron trivalent, parenteral preparations | |
Migraines | N02C | Antimigraine preparations |
Pain | N02A, N02B | Opioids |
Other analgesics | ||
Parkinson’s disease | N04 | Anti-parkinson drugs |
Psycholgical disorders (sleep disorder, depression) | N05B, N05C, | Anxiolytics |
N06A | Hypnotics and sedativesAntidepressants | |
Psychoses | N05A | Antipsychotics |
Respiratory illness (asthma, COPD) | R03 | Drugs for obstructive airway diseases |
Rheumatologic conditions | M01, M02 | Antiflammatory and antirheumatic products |
L04AA, L04AB | Topical products for joint and muscular pain | |
Selective immunosuppressants | ||
TNF-alpha inhibitors | ||
Thyroid disorders | H03 | Drugs for thyroid therapy |
Tuberculosis | J04A | Drugs for treatment of tuberculosis |